RBC Capital Maintains Outperform Rating on Repligen, Keeps $200 Target
RBC Capital maintained its Outperform rating and $200 price target on Repligen. The target implies 13.8% upside from the Oct. 27 close of $175.80.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.